Sales manager forwarded information from the nurse: all was going well until the fifth cycle.Patient was drinking some warm soup and the said she felt not well.The patient reported nausea and then fainted.Hypotension.No pulse measurable.Bp 60/40.Actions taken: trendelenburg position.1000ml nacl 0.9% infusion, no transfusion.Small blood count.Continued monitoring ecg - pulse - saturation - bp paspertin 50mg (for nausea).After 10 minutes the patient recovered, treatment was continued and could be completed.Patient was well afterwards, parameters were stable.She was currently in another ecp procedure, all going well.No product was returned.Patient was already hospitalized (pneumology), independent from ecp, no prolongation due to this event.
|
A review of lot c751 was performed and there were no nonconformances associated with this lot.This lot met release requirements.Trends were reviewed for complaint categories, fainting, hypotension, nausea, and dizziness, and no trends were detected.There was no capa initiated.This assessment is based on information available at the time of this report.No product was returned for evaluation; therefore, it could not be determined if this specific product met specifications.Based on internal medical assessment, (b)(6), during treatment not feeling well, nausea, then fainted.Administered 1000 ml nacl and parpertin for nausea.Patient recuperated and treatment resumed.Case is being reported due to medical intervention.(b)(4).
|